Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Esketamine, a molecular relative of regular ... Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato ...
Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...
"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at ...
Spravato (esketamine) has possible interactions with ... Is it safe to use a nasal corticosteroid or decongestant during Spravato treatment? Yes, it’s likely safe. But you should take doses ...
Ketamine has promise as a potential treatment for bipolar depression, particularly for people whose condition hasn’t ...
One recent novel addition to the treatment toolbox for TRD is esketamine nasal spray (Spravato), which has been shown to rapidly relieve depressive symptoms when combined with an oral ...
A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.